I can hardly imagine any rational that can explain all of
I can hardly imagine any rational that can explain all of that behavior that we are currently seeing from the GNBT management team.
But no one of us really has a clue what is really going on either. There are a couple of contradictory information that we received and acquired as a collective.
You listed a good part of the negatives in your previous post.
I hold the following points against thase items.
* Todd is still very much responsive, at least as long as one does not ask to concrete questions.
* RJ just found out that Bintai Kinden is still counting on the agreements they have signed with the companies.
* the roll out of Excellegen sounded almost like a done deal during the time of the last CC in May. I don't see any reason why this detailed plan that was explained to us, would not be realized in the meantime. According to this plan, by now they should be making millions of dollars in Excellegen sales. Why would a company go bankrupt with such a product in their portfolio?
* besides the entire Corona vaccine story, the valuation of NGIO is independently estimated to be in the hundreds of millions. Why would such a company go bankrupt?
* the company and Joe have been very outspoken and communicative in the previous years, and all of a sudden they stop communicating entirely and when asked the only statement we receive is a "we cannot provide updates at this time". This to me speaks volumes about the fact that some outside forces cause them to do so, and it is not just them who change their personalities in no time.
So looking at your list, of course, things don't look good, but this stands in direct contrast to my list above. Whatever is really going and how this could all be explained is something that no one of us seems to be able to say.
3
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
No Smooth Sailing in HBX's Waters Tell you what, HBX Group's third-quarter update feels like a mixed bag of tricks. They’ve pulled off a decent 12% boost in Total Transaction Value (TTV), hitting €2.4 billion. Now, that’s an eyebrow-raiser in this market, especially when leisure travel's still rebounding. But, and there’s always a but, revenue's slid 3%...
Continue Reading
Beam Global Announces Strong Second Quarter Results Beam Global, a renowned provider of sustainable infrastructure solutions focused on electrification and energy security, has recently unveiled impressive financial results for the second quarter. This announcement reinforces Beam's commitment to growth and innovation within the clean energy sector. Financial Highlights...
Continue Reading
Dispelix and RTX's Collins Aerospace Join Forces Dispelix, a leader in augmented reality (AR) waveguide display technology, and Collins Aerospace, part of RTX, have embarked on a transformative partnership. This collaboration is centered around a long-term supply agreement aimed at integrating Dispelix's cutting-edge AR waveguide displays into Collins Aerospace's...
Continue Reading
Dundee Precious Metals Provides Update on the ?oka Rakita Project Today, Dundee Precious Metals Inc. (TSX: DPM) announced important updates regarding the ?oka Rakita project. The company's latest report confirms that the pre-feasibility study (PFS) is set for completion in early 2025, indicating a positive trajectory for the project's growth. Additionally, new assay...
Continue Reading
Citi Adjusts Cadence BanCorp Price Target Citi has recently updated its outlook for Cadence BanCorp (NYSE: CADE), maintaining a Neutral rating while elevating the price target to $37 from $35. This revision comes as analysts foresee continued net interest margin (NIM) expansion paired with prudent cost management strategies that are expected to benefit the bank in the...
Continue Reading